Akums Drugs and Pharmaceuticals has received a certificate confirming compliance with SEBI’s Depositories and Participants Regulations for the quarter ending September 30, 2025. The certificate, received from MUFG Intime India, Registrar & Share Transfer Agent (RTA), confirms that the company has adhered to the regulations regarding dematerialization of securities.
Compliance Confirmation
Akums Drugs and Pharmaceuticals has received confirmation of compliance with the Depositories and Participants Regulations. This relates to the handling of securities for dematerialization.
Key Highlights
The certificate, provided by MUFG Intime India Private Limited, the Registrar & Share Transfer Agent (RTA), covers the period ending September 30, 2025.
MUFG Intime’s Confirmation
MUFG Intime confirms that securities received for dematerialization during the quarter were properly handled. This includes confirming acceptance/rejection to the depositories, ensuring listed securities, and proper cancellation/mutilation of certificates after verification.
Source: BSE
